Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mya arenaria, a common clam species, has a single p63/p73 hybrid-like gene but can splice the transcripts from this gene into a p53-like sequence and a p63/p73-like sequence.”
From The Origins and Evolution of the p53 Family of Genes (2010) · cites this paper as Kelley et al. 2001
In the citing paper
“The p53 isoform behaves like a functional p53 because clams can develop leukemia and in many cases p53 (in the p63/73 gene) mutations are found in the leukemic cells from this organism”
From The Origins and Evolution of the p53 Family of Genes (2010) · cites this paper as Kelley et al. 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“The DBDs of Hsp53 contain 80 ± 90% of the known mutations that have been described in a wide variety of human cancers (Cho et al., 1994; Greenblatt et al., 1994).”
BackgroundStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · cited 2×
“Amino acid residues F19, W23 and L26 Oncogene present in Hsp53 and essential for binding, MDM2 (HDM2 in humans) are conserved in the clam homologues (Figure 2; Kussie et al., 1996; Dobbelstein et al., 1998).”
BackgroundDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 1×
“Alternatively, abnormal p53 activity may result from di erential expression and degradation (Shieh et al., 1997) and phosphorylation and acetylation (Burns and El-Diery, 1999).”
BackgroundActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · cited 2×
“…identity to the Hsp53 TAD suggests that Map53/73 may be responsible for the transactivation of genes involved in: (a) negative regulation of p53 (Honda et al., 1997); (b) DNA editing and repair (Tanaka et al., 2000) and (c) apoptosis (Miyashita et al., 1994; O'Connor et al., 1997; Avramis et…”
BackgroundEnhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904 · cited 2×
“…suggests that Map53/73 may be responsible for the transactivation of genes involved in: (a) negative regulation of p53 (Honda et al., 1997); (b) DNA editing and repair (Tanaka et al., 2000) and (c) apoptosis (Miyashita et al., 1994; O'Connor et al., 1997; Avramis et al., 1998; Tanaka et al., 2000).”
BackgroundStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738 · cited 1×
“In Hsp53, the nuclear export signal is a leucine rich sequence, MFXXLXXXLXL (Stommel et al., 1999); a similar sequence (MLXXIXXXLXI) is also present in the tetramerization domain of Map53/73.”
BackgroundMDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 1×
“Although Hsp73 can bind MDM2, it is not targeted for degradation by MDM2 (Balint et al., 1999; Zeng et al., 1999; Momand et al., 2000).”
Background
Research works printed but not linked: 45
- Baine B. . 1999 Leukemia Diagnosis. Blackwell Science, 2nd edn., London pp.1–200.
- Barker CM, Calvert RJ, Walker CW and Reinisch CL. . 1997 Detection of mutant p53 in clam leukemia cells. Exp. Cell. Res. 232: 240–245. · doi:10.1006/excr.1997.3513
- Bhaskaran A, May D, Rand-Weaver M and Tyler CR. . 2000 Comp. Biochem. Physiol. 126: 49–57. · DOI
- Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM and Abrams JM. . 2000 Cell 101: 103–113. · DOI · Paper page
- Burns TF and El-Diery WS. . 1999 J. Cell. Physiol. 181: 231–239. · DOI
- Cheng TC. . 1981 Invertebrate Blood Cells. Academic Press, London pp.233–300.
- De Laurenzi V, Cotsanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M and Melino G. . 1998 J. Exp. Med. 188: 1763–1768. · DOI · Paper page
- Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV and Fojo T. . 2000 Nat. Cell. Biol. 2: 709–717. · DOI · Paper page
- Grogan TM, Warnke RA and Kaplan HS. . 1982 Cancer 49: 1817–1828. · doi:10.1002/1097-0142(19820501)49:9<1817::aid-cncr2820490914>3.0.co;2-f
- Harlow E and Lane D. . 1999 Using Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY pp.1–495.
- Kaelin WG. . 1999 Oncogene 18: 7701–7705. · DOI · Paper page
- Kaghad M, Bonnet H, Yang A, Creancier L, Biscan Y-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819. · DOI · Paper page
- Kim IS, Kim D-H, Han S-M, Chin MU, Nam H-J, Cho H-P, Choi SY, Song B-J, Kim S-R, Bae Y-S and Moon Y-H. . 2000 J. Biol. Chem. 275: 23139–23145. · DOI · Paper page
- Kozak M. . 1987 Nucleic Acids Res. 15: 8125–8148. · DOI · Paper page
- Kozak M. . 1989 J. Cell. Biol. 108: 229–241. · DOI · Paper page
- Levrero M, De Laurenzi V, Contanzo A, Gong J, Melino G and Wang JY. . 1999 Cell Death Differ. 6: 1146–1153. · DOI
- Liang S-H and Clarke MF. . 1999 J. Biol. Chem. 274: 32699–32703. · DOI · Paper page
- Liu Y, Colosimo L, Yang XJ and Liao D. . 2000 Mol. Cell. Biol. 20: 5540–5553. · DOI · Paper page
- Lu W, Pochampally R, Chen L, Traidej M, Wang Y and Chen J. . 2000 Oncogene 19: 232–240. · DOI
- May P and May E. . 1999 Oncogene 18: 7621–7636. · DOI · Paper page
- Marin MC and Kaelin WG. . 2000 Biochem. Biophys. Acta 1470: 94–100. · DOI
- Miosky DL, Smolowitz RM and Reinisch CL. . 1989 J. Invert. Pathol. 53: 32–40. · doi:10.1016/0022-2011(89)90071-2
- Moll UM, Riou G and Levine AJ. . 1992 Proc. Natl. Acad. Sci. 89: 7262–7266. · DOI · Paper page
- Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M and Zambetti G. . 1996 Mol. Cell. Biol. 16: 1126–1137. · DOI · Paper page
- Nagai J, Kigasawa H, Koga N, Katoh A, Nishihira H and Nagao T. . 1998 Leuk. Lymphoma. 28: 591–597. · DOI
- Nishimori H, Nishikawa R, Fujimaki T, Nakagomi T, Matsutani M, Huang HJ and Cavanee WK. . 2000 J. Neurooncol. 46: 17–22. · DOI
- Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, Duyk G, Friedman L, Prives C and Kopczynski C. . 2000 Cell 101: 91–101. · DOI · Paper page
- Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S. . 1998 Nature Med. 4: 839–843. · DOI · Paper page
- Page R. . 1996 Comput. Appl. Biosci. 12: 357–358. · DOI · Paper page
- Pozniak CD, Radinovic S, Yang A, McKean F, Kaplan DR and Miller FD. . 2000 Science 289: 304–306. · DOI · Paper page
- Prokocimer M, Shaklai M, Bassett HB, Wolf D, Goldfinger N and Rotter V. . 1986 Blood 68: 113–118. · doi:10.1182/blood.v68.1.113.bloodjournal681113
- Reinisch CL, Charles AM and Stone AM. . 1984 Hazardous Waste 1: 73–81. · doi:10.1089/hzw.1984.1.73
- Sambrook J, Fritsch EF and Maniatus T. . 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Press.
- Schlamp CL, Poulsen GL, Nork TM and Nickells RW. . 1997 J. Natl. Cancer Inst. 89: 1530–1536. · DOI · Paper page
- Schmale H and Bamberger C. . 1997 Oncogene 15: 1363–1367. · DOI · Paper page
- Senoo M, Seki N, Ohira M, Sugano S, Watanabe M, Tachibana T, Shinkai Y and Kato H. . 1998 Biochem. Biophys. Res. Comm. 248: 603–607. · DOI
- Steller H. . 2000 Nature Cell Biol. 2: 100–102. · DOI
- Sunahara M, Shishikura T, Takahashi M, Todo S, Yamamoto N, Kimura H, Kato S, Ishika C, Ikawa S, Ikawa Y and Nakagawara A. . 1999 Oncogene 18: 3761–3765. · doi:10.1038/sj.onc.1202972
- Thanos C and Bowie J. . 1999 Protein Sci. 8: 1708–1710. · DOI
- Thompson JD, Higgins DG and Gibson TJ. . 1994 Nucleic Acids Res. 22: 4673–4680. · DOI · Paper page
- Trink B, Okami K, Wu L, Sriuranpong V, Jen J and Sidransky D. . 1998 Nature Med. 4: 747–748. · DOI · Paper page
- Van Beneden RJ, Rhodes LD and Gardner GR. . 1998 Mar. Environ. Res. 46: 209–213. · doi:10.1016/s0141-1136(97)00093-7
- Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L and Debussche L. . 1998 EMBO J. 17: 4668–4679. · DOI · Paper page
- Walker XW and Levine AJ. . 1996 PNAS 93: 15335–15340. · DOI · Paper page
- Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. . 1998 Mol. Cell 2: 305–316. · DOI · Paper page
Cited by
Ecotoxicological applications and significance of the comet assay
Jha, A. N. (2008) · Mutagenesis · doi:10.1093/mutage/gen014 · Cited by 477
Lesser, M. P., & Farrell, J. H. (2004) · Coral Reefs · doi:10.1007/s00338-004-0392-z · Cited by 464
Self-citationThe Origins and Evolution of the p53 Family of Genes
Belyi, V. A., Ak, P., Markert, E., Wang, H., Hu, W., Puzio-Kuter, A., & Levine, A. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001198 · Cited by 344
Metadata
- Authors
- Kelley, M. L., Winge, P., Heaney, J. D., Stephens, R. E., Farell, J. H., Van Beneden, R. J., Reinisch, C. L., Lesser, M. P., & Walker, C. W.
- Venue
- Oncogene
- Published
- 2001-02-08
- Volume
- 20
- Issue
- 6
- Pages
- 748-758
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 77
- References
- 14
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.